GenFleet Therapeutics is based in Shanghai, China. It has raised $343M in total funding. Latest round: Series B.
GenFleet Therapeutics is based in Shanghai, China. GenFleet Therapeutics has raised $343M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in March 2020. The round record for GenFleet Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include CDH Investments, Shenzhen Capital Group, South China Venture Capital, Panlin Capital, Sinopharm Capital, Lakebleu Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Every GenFleet Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026